These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3739586)

  • 21. Liquid chromatographic determination of propoxyphene and norpropoxyphene in plasma and breast milk.
    Kunka RL; Yong CL; Ladik CF; Bates TR
    J Pharm Sci; 1985 Jan; 74(1):103-4. PubMed ID: 3981406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Propoxyphene and norpropoxyphene: pharmacologic and toxic effects in animals.
    Nickander R; Smits SE; Steinberg MI
    J Pharmacol Exp Ther; 1977 Jan; 200(1):245-53. PubMed ID: 13200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marked QRS complex abnormalities and sodium channel blockade by propoxyphene reversed with lidocaine.
    Whitcomb DC; Gilliam FR; Starmer CF; Grant AO
    J Clin Invest; 1989 Nov; 84(5):1629-36. PubMed ID: 2553778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dextropropoxyphene poisoning: problems with interpretation of analytical data.
    Buckley BM; Vale JA
    Hum Toxicol; 1984 Aug; 3 Suppl():95S-101S. PubMed ID: 6480021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of ethanol intake on propoxyphene absorption and biotransformation in dogs.
    Olsen H; Aune H; Lilleaasen P; Gulliksen M; Bodd E; Mørland J
    Alcohol Clin Exp Res; 1986 Aug; 10(4):393-6. PubMed ID: 3530016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Propoxyphene and norpropoxyphene: influence of diet and fluid on plasma levels.
    Welling PG; Lyons LL; Tse FL; Craig WA
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):559-65. PubMed ID: 1277712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-poisoning with dextropropoxyphene and dextropropoxyphene compounds: the USA experience.
    Finkle BS
    Hum Toxicol; 1984 Aug; 3 Suppl():115S-134S. PubMed ID: 6480011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardio-respiratory toxicity of propoxyphene and norpropoxyphene in conscious rabbits.
    Lund-Jacobsen H
    Acta Pharmacol Toxicol (Copenh); 1978 Mar; 42(3):171-8. PubMed ID: 580345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal and fetal blood/brain distribution of d-propoxyphene and norpropoxyphene in rat and dog.
    Due SL; Sullivan HR; Cochrane RL; Page JG; McMahon RE
    Toxicol Appl Pharmacol; 1981 Apr; 58(2):194-202. PubMed ID: 7245195
    [No Abstract]   [Full Text] [Related]  

  • 30. d-Propoxyphene kinetics after single oral and intravenous doses in man.
    Gram LF; Schou J; Way WL; Heltberg J; Bodin NO
    Clin Pharmacol Ther; 1979 Oct; 26(4):473-82. PubMed ID: 487695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Propoxyphene and norpropoxyphene: influence of type of controlled-release formulation on intra- and intersubject variations.
    Bechgaard H; Baggesen S
    J Pharm Sci; 1980 Nov; 69(11):1327-30. PubMed ID: 7452465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of new d-propoxyphene derivatives and the development of a microparticle-based immunoassay for the detection of propoxyphene and norpropoxyphene.
    Wu RS; McNally AJ; Pilcher IA; Salamone SJ; Rashid S
    Bioconjug Chem; 1997; 8(3):385-90. PubMed ID: 9177845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethanol does not increase lethality due to propoxyphene in rats.
    Bodd E; Olsen H; Gulliksen M; Mørland J
    Alcohol; 1985; 2(2):293-6. PubMed ID: 4015849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic interaction of propoxyphene with ethanol.
    Sellers EM; Hamilton CA; Kaplan HL; Degani NC; Foltz RL
    Br J Clin Pharmacol; 1985 Mar; 19(3):398-401. PubMed ID: 3986091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous quantitation of meperidine, normeperidine, tramadol, propoxyphene and norpropoxyphene in human plasma using solid-phase extraction and gas chromatography/mass spectrometry: Method validation and application to cardiovascular safety of therapeutic doses.
    Fernández N; Olivera NM; Keller GA; Diez RA; Di Girolamo G; Quiroga PN
    Rapid Commun Mass Spectrom; 2017 Sep; 31(18):1519-1533. PubMed ID: 28686794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Propoxyphene and norpropoxyphene quantitation in the same solid-phase extraction using Toxi-Lab Spec VC MP3 system.
    King JW; King LJ
    J Anal Toxicol; 1994; 18(4):217-9. PubMed ID: 7967543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GLC determination of paracetamol and d-propoxyphene.
    Serfontein WJ; de Villiere LS; Villiers LS; Botha D
    S Afr J Med Sci; 1976; 41(4):297-304. PubMed ID: 1019754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Propoxyphene and norpropoxyphene kinetics after single and repeated doses of propoxyphene.
    Inturrisi CE; Colburn WA; Verebey K; Dayton HE; Woody GE; O'Brien CP
    Clin Pharmacol Ther; 1982 Feb; 31(2):157-67. PubMed ID: 7056023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute propoxyphene self-poisoning in 222 consecutive patients.
    Sloth Madsen P; Strøm J; Reiz S; Bredgaard Sørensen M
    Acta Anaesthesiol Scand; 1984 Dec; 28(6):661-5. PubMed ID: 6524282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of evidence of increased lethality due to propoxyphene overdose in the presence of ethanol in male Wistar rats.
    Bodd E; Olsen H; Gulliksen M; Mørland J
    Arch Toxicol; 1985 Jan; 56(3):170-4. PubMed ID: 3977596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.